News

Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out
Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...
Patients Cut Off From Cheaper Obesity Drugs as the F.D.A. Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Everything to know about the new weight loss pill that works as well as Ozempic — and when you can get it
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Verywell Health on MSN1d
Zepbound Helps Keep Weight Off for 3 Years, Study Finds
Fact checked by Nick Blackmer Zepbound supports sustained weight loss for up to three years among adults with obesity and ...
Diabetes and weight-loss drug ‘changed my life,’ says senator: ‘I feel a decade younger’
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...
Futurism on MSN18h
Novo Nordisk Is Getting Absolutely Destroyed
Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.
Weight loss drugs may be ‘game changer’ for breast cancer patients with lymphedema
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...